company background image
CVRX logo

CVRx NasdaqGS:CVRX Stock Report

Last Price

US$6.31

Market Cap

US$170.0m

7D

1.8%

1Y

-61.5%

Updated

15 Apr, 2025

Data

Company Financials +

CVRx, Inc.

NasdaqGS:CVRX Stock Report

Market Cap: US$170.0m

CVRX Stock Overview

A commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. More details

CVRX fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Revenue is forecast to grow 18.77% per year

Risk Analysis

Currently unprofitable and not forecast to become profitable over the next 3 years

Volatile share price over the past 3 months compared to the US market

Shareholders have been diluted in the past year


Community vs My Fair Value

Select a narrative for quick price alerts from the community, or create your own.

CVRX logo
CVRx
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts

Expanding 48 US Territories And New Codes Will Broaden Access

Key Takeaways Expansion in US territories and implanting centers is expected to drive significant revenue growth and market penetration. Stabilizing sales force and improvements in reimbursement structures plus education initiatives aim to enhance adoption rates and boost revenues.
View narrative
US$16.83
FV
62.5% undervalued intrinsic discount
24.40%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
6 days ago author updated this narrative
View CVRx Community

CVRx, Inc. Competitors

Myomo

NYSEAM:MYO

US$153.0m

Orchestra BioMed Holdings

NasdaqGM:OBIO

US$107.3m

SANUWAVE Health

NasdaqGM:SNWV

US$260.4m

LENSAR

NasdaqCM:LNSR

US$161.3m

Price History & Performance

Summary of share price highs, lows and changes for CVRx
Historical stock prices
Current Share PriceUS$6.31
52 Week HighUS$18.55
52 Week LowUS$5.87
Beta1.29
1 Month Change-44.84%
3 Month Change-62.88%
1 Year Change-61.48%
3 Year Change27.47%
5 Year Changen/a
Change since IPO-77.46%

Recent News & Updates

CVRx, Inc.: Overreaction Creates Buying Opportunity

Apr 09
author-image

Expanding 48 US Territories And New Codes Will Broaden Access

Mar 29 Expansion in US territories and implanting centers is expected to drive significant revenue growth and market penetration.

With A 29% Price Drop For CVRx, Inc. (NASDAQ:CVRX) You'll Still Get What You Pay For

Mar 07
With A 29% Price Drop For CVRx, Inc. (NASDAQ:CVRX) You'll Still Get What You Pay For

Recent updates

CVRx, Inc.: Overreaction Creates Buying Opportunity

Apr 09
author-image

Expanding 48 US Territories And New Codes Will Broaden Access

Mar 29 Expansion in US territories and implanting centers is expected to drive significant revenue growth and market penetration.

With A 29% Price Drop For CVRx, Inc. (NASDAQ:CVRX) You'll Still Get What You Pay For

Mar 07
With A 29% Price Drop For CVRx, Inc. (NASDAQ:CVRX) You'll Still Get What You Pay For

Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 27%

Jan 16
Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 27%

Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?

Dec 26
Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?

CVRx: Impressive Top-Line Growth Seems Priced In

Nov 07

Analyst Estimates: Here's What Brokers Think Of CVRx, Inc. (NASDAQ:CVRX) After Its Third-Quarter Report

Nov 01
Analyst Estimates: Here's What Brokers Think Of CVRx, Inc. (NASDAQ:CVRX) After Its Third-Quarter Report

Investors Still Waiting For A Pull Back In CVRx, Inc. (NASDAQ:CVRX)

Oct 10
Investors Still Waiting For A Pull Back In CVRx, Inc. (NASDAQ:CVRX)

Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?

Jul 31
Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By CVRx, Inc.'s (NASDAQ:CVRX) 32% Share Price Surge

Jun 18
Why Investors Shouldn't Be Surprised By CVRx, Inc.'s (NASDAQ:CVRX) 32% Share Price Surge

The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 47%

May 04
The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 47%

Rock star Growth Puts CVRx (NASDAQ:CVRX) In A Position To Use Debt

Apr 10
Rock star Growth Puts CVRx (NASDAQ:CVRX) In A Position To Use Debt

The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 25%

Feb 29
The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 25%

Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 34%

Nov 11
Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 34%

Companies Like CVRx (NASDAQ:CVRX) Are In A Position To Invest In Growth

Aug 20
Companies Like CVRx (NASDAQ:CVRX) Are In A Position To Invest In Growth

CVRx Pursues Revenue Growth But Operating Losses Worsen

Aug 05

Shareholder Returns

CVRXUS Medical EquipmentUS Market
7D1.8%2.8%6.8%
1Y-61.5%2.9%5.9%

Return vs Industry: CVRX underperformed the US Medical Equipment industry which returned 2.9% over the past year.

Return vs Market: CVRX underperformed the US Market which returned 5.9% over the past year.

Price Volatility

Is CVRX's price volatile compared to industry and market?
CVRX volatility
CVRX Average Weekly Movement16.1%
Medical Equipment Industry Average Movement9.0%
Market Average Movement7.7%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market4.1%

Stable Share Price: CVRX's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: CVRX's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2000206Kevin Hykeswww.cvrx.com

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors.

CVRx, Inc. Fundamentals Summary

How do CVRx's earnings and revenue compare to its market cap?
CVRX fundamental statistics
Market capUS$170.02m
Earnings (TTM)-US$59.96m
Revenue (TTM)US$51.29m

3.2x

P/S Ratio

-2.7x

P/E Ratio

Is CVRX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CVRX income statement (TTM)
RevenueUS$51.29m
Cost of RevenueUS$8.33m
Gross ProfitUS$42.96m
Other ExpensesUS$102.92m
Earnings-US$59.96m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

May 08, 2025

Earnings per share (EPS)-2.30
Gross Margin83.75%
Net Profit Margin-116.91%
Debt/Equity Ratio69.3%

How did CVRX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/15 00:47
End of Day Share Price 2025/04/15 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CVRx, Inc. is covered by 8 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
William PlovanicCanaccord Genuity
Ross OsbornCantor Fitzgerald & Co.
Chase KnickerbockerCraig-Hallum Capital Group LLC